Launch week offerEnds in00h00m00s
annual Promonthly Pro
Benedicte Leynaert
Researcher
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (16)
Year:
2026
Year:
2025
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Background Few population‐based studies have described allergic rhinitis (AR) according to the Allergic Rhinitis and its Impact on Asthma (ARIA) classification, and none have assessed the impact of asthma on this classification. Our aims were to 1) describe AR according to four ARIA classes and 2) within each of the four ARIA classes, compare participants with AR alone versus those with AR and asthma. Methods Cross‐sectional analyses were performed using data from the 2014 annual follow‐up questionnaire of the French adult population‐based cohort Constances. Current AR was defined by the report of sneezing, runny, or blocked nose in the last 12 months and the report of nasal allergies. Following ARIA recommendations, rhinitis was classified according to its severity (mild or moderate‐severe) and duration (intermittent or persistent). Ever asthma was also defined by a questionnaire. Results Among the 4675 participants with AR (57% women, mean age 50.2 ± 12.7 years), 44% were classified as mild/intermittent, 16% mild/persistent, 25% moderate‐severe/intermittent, and 15% moderate‐severe/persistent. Within each of the four ARIA classes, compared to participants with rhinitis alone, participants with rhinitis and asthma had significantly more severe symptoms, more conjunctivitis, a higher mean eosinophil count and more treatments with intra‐nasal corticosteroids and oral antihistamines co‐medication. Conclusions This is a paradigm shift study as for the first time this large population‐based study in adults showed that asthma status has a profound effect on the ARIA classification. Rhinitis alone and rhinitis with asthma represent two distinct phenotypes. These results reinforce the need to include asthma status in the ARIA classification and guidelines.
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Collaborators (18)
Maritta S. Jaakkola
-
Iana Markevych
Research group leader
Jagiellonian University
Julia Dratva
Co-head of institute
ZHAW Zürcher Hochschule für Angewandte Wissenschaften
Annabelle Bédard
Université Paris-Saclay
Amandine Divaret-Chauveau
University Hospital of Nancy
Judith Garcia Aymerich
Research Professor and Head of the Non-Communicable Diseases and Environment Programme
Instituto de Salud Global Barcelona
nicolas roche
-
Andre F. S. Amaral
Imperial College London
Caroline Lodge
University of Melbourne
José Antonio Gullón
Profesor asociado
University of Oviedo
Rachel Nadif
Senior researcher, member of the Integrative Respiratory Epidemiology team
INSERM
Danielle Vienneau
Universitair Medisch Centrum Utrecht
Elaine Fuertes
Epidemiologist
Helmholtz Zentrum München Deutsches Forschungszentrum für Umwelt und Gesundheit
Joachim Heinrich
-
Jouni J. K. Jaakkola
University of Oulu
Mathias Holm
University of Gothenburg
Nicole Le Moual
INSERM
Marie Aline Charles
Research Director
Université Paris Descartes
Make your next move.
Prepare your application
Review drafts before you send them.